Cytosorbents Corp - Common Stock (CTSO)

CUSIP: 23283X206

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
63,013,241
Total 13F shares
16,466,687
Share change
-917,883
Total reported value
$11,576,845
Put/Call ratio
5%
Price per share
$0.70
Number of holders
44
Value change
-$649,269
Number of buys
10
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 23283X206?
CUSIP 23283X206 identifies CTSO - Cytosorbents Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cytosorbents Corp - Common Stock (CTSO) as of Q2 2024

As of 30 Jun 2024, Cytosorbents Corp - Common Stock (CTSO) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,466,687 shares. The largest 10 holders included AVENIR CORP, Skylands Capital, LLC, Granahan Investment Management, LLC, VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, Sargent Investment Group, LLC, CM Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.